At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Ketaminedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cardiovascular and Neuropsychiatric Side Effects in Ketamine Analgesic Infusions in Acute Pain
In Brief
An observational study evaluating Ketamine for Pain and 2 related conditions. Completed, enrolled 300 participants across 2 sites.
Detailed Summary
Observational study that evaluate the cardiovascular and neuropsychiatric side effects of ketamine analgesic infusions for acute pain
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Ketamine Adverse Reaction, Postoperative Pain
CountriesColombia
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
Primary CompletionNov 2018
Study CompletionDec 2018
First PostedJun 2019
TodayJul 2026
First PostedJun 7, 2019
Enrollment StartJul 1, 2017
Primary CompletionNov 1, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.1 years ago
Interventions
Ketaminedrug
Drug: Ketamine Side effects associated with ketamine infusion to treat acute pain, were reviewed after 48 hours of exposure and frequency of tachycardia, hypertension, hallucinations, delirium and nightmares were registrated for comparison